| Literature DB >> 35879377 |
Maria Araceli Diaz Cruz1, Benjamin Ulfenborg2, Peter Blomstrand3,4,5, Maria Faresjö6, Fredrik Ståhl7, Sandra Karlsson8.
Abstract
Numerous studies have shown that lifestyle factors, such as regular physical activity and vitamin D intake, may remarkably improve overall health and mental wellbeing. This is especially important in older adults whose vitamin D deficiency occurs with a high prevalence. This study aimed to examine the influence of lifestyle and vitamin D on global DNA methylation patterns in an elderly cohort in Southwest of Sweden. We also sought to examine the methylation levels of specific genes involved in vitamin D's molecular and metabolic activated pathways. We performed a genome wide methylation analysis, using Illumina Infinium DNA Methylation EPIC 850kBeadChip array, on 277 healthy individuals from Southwest Sweden at the age of 70-95. The study participants also answered queries on lifestyle, vitamin intake, heart medication, and estimated health. Vitamin D intake did not in general affect methylation patterns, which is in concert with other studies. However, when comparing the group of individuals taking vitamin supplements, including vitamin D, with those not taking supplements, a difference in methylation in the solute carrier family 25 (SCL25A24) gene was found. This confirms a previous finding, where changes in expression of SLC25A24 were associated with vitamin D treatment in human monocytes. The combination of vitamin D intake and high physical activity increased methylation of genes linked to regulation of vitamin D receptor pathway, the Wnt pathway and general cancer processes. To our knowledge, this is the first study detecting epigenetic markers associated with the combined effects of vitamin D supplementation and high physical activity. These results deserve to be further investigated in an extended, interventional study cohort, where also the levels of 25(OH)D3 can be monitored.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35879377 PMCID: PMC9310683 DOI: 10.1038/s41598-022-15924-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Background data among participants in the methylation study (n = 274).
| Gender | Female (n = 188) | Male (n = 81) | Total (n = 269, n/a = 5) |
| Age (mean ± SD) | 75.1 ± 5.8 | 76.1 ± 4.9 | 75.4 ± 5.5 |
| Self-reported health status (SRHS) | |||
| 84 | 31 | 115 | |
| 94 | 47 | 141 | |
| 4 | 4 | 8 | |
| Medicine: Lipids | |||
| 130 | 52 | 182 | |
| 35 | 20 | 55 | |
| Medicine: Blood pressure | |||
| 108 | 39 | 147 | |
| 70 | 40 | 110 | |
| Medicine: Heart | |||
| 133 | 51 | 184 | |
| 29 | 22 | 51 | |
*n number of samples.
n/a no answer.
Figure 1(A) PCA on pre-processed methylation data showing differences between female and male individuals in the study (n = 269, n/a = 5). (B) Volcano Plot representing DMPs between females (n = 188) and males (n = 81). Red: Hypermethylated probes: differences in beta-values (β) > 0.2 and false discovery rate (FDR) < 0.05. Blue: Hypomethylated probes: β < -0.2 and FDR < 0.05. Black: Non-significant results. Gene names are shown for DMPs with β > 0.5 and FDR < 0.0001, and DMPs with β < -0.5 and FDR < 0.0001.
DMPs in the group of individuals taking vitamin D supplements and exerting high levels of physical activity.
| Gene name | Gene symbol | Probe | Chr | FDR | β |
|---|---|---|---|---|---|
| cg21886364 | 5 | 6.5E-07 | 0.28 | ||
| cg07145979 | 5 | 7E-07 | 0.28 | ||
| cg17573292 | 4 | 2.7E-06 | 0.34 | ||
| cg13488570 | 1 | 4.5E-06 | 0.23 | ||
| Lipin 1 | cg00523161 | 2 | 4.5E-06 | 0.34 | |
| Intergenic region | cg24792289 | 5 | 4.5E-06 | 0.27 | |
| Intergenic region | cg23244910 | 6 | 6.9E-06 | 0.28 | |
| GLI family zinc finger 3 | cg06310816 | 7 | 2.1E-05 | 0.20 | |
| cg26426745 | 1 | 2.4E-05 | 0.35 | ||
| cg15295273 | 17 | 2.4E-05 | 0.31 | ||
| cg08454053 | 17 | 3.2E-05 | 0.24 | ||
| KIAA0319-like | cg22698544 | 1 | 7.1E-05 | 0.26 | |
| Intergenic region | cg05964935 | Y | 7.1E-05 | -0.29 | |
| cg20008148 | 14 | 8.8E-05 | 0.36 | ||
| cg04934246 | 11 | 2.3E-04 | 0.21 | ||
| Intergenic region | cg16668359 | 2 | 2.3E-04 | 0.31 | |
| cg20116828 | 19 | 3E-04 | 0.38 | ||
| Intergenic region | cg20586840 | 4 | 3.3E-04 | -0.21 | |
| cg16562217 | 3 | 3.7E-04 | 0.56 | ||
| Intergenic region | cg13100965 | 7 | 3.8E-04 | 0.31 |
*FDR False discovery rate; Chr chromosome, β beta value difference.
Functional annotation analysis of differentially methylated genes associated with vitamin D supplements and high physical activity group.
| GO category | Term | # genes | FDR |
|---|---|---|---|
| Molecular function (MF) | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 30 | 0.02 |
| DNA-binding transcription activator activity, RNA polymerase II-specific | 17 | 0.03 | |
| Protein binding | 181 | 0.04 | |
| Biological process (BP) | Positive regulation of transcription by RNA polymerase II promoter | 35 | 0.002 |
| Cell adhesion | 27 | 0.007 | |
| Regulation of cell population proliferation | 36 | 0.03 |
*# genes: Number of genes, FDR False discovery rate.
Figure 2Main regulated pathways related to genes with differentially hypermethylated probes found in the vitamin D and high physical activity group. (A) Top 7 significant regulated pathways obtained with Wikipathways in GeneCodis, adjusted P value < 0.05. (B) Top 10 significant regulated pathways obtained with KEGG, adjusted P value < 0.05.
Figure 3Association of methylation levels of CpGs at RXRA, PPARGC1B, SMARCA4, SMARCC1, COSP2, and ACSL1; and age of the individuals in the study. Association was evaluated by Spearman's correlation method (r2, P value < 0.05).